Rapid growth in infectious disease and cancer immunotherapy applications; Lipid nanoparticles lead delivery methods, while polymeric carriers are expected to grow rapidly.
Austin, Oct. 28, 2025 (GLOBE NEWSWIRE) — mRNA Technology Market Size & Growth Analysis:
According to SNS Insider, the global mRNA technology market is estimated to have reached a valuation of USD 35.67 billion in 2023 and is projected to grow at an impressive compound annual growth rate (CAGR) of 8.88% during the forecast period 2024-2032 to reach USD 76.45 billion by 20232. This significant growth is being driven by the unprecedented success of mRNA vaccines during the COVID-19 pandemic and the increasing use of this technology in cancer treatment, which is ushering in a new revolution in global healthcare.
There are several advantages of mRNA technology behind this growth. These include a shorter lead time, higher efficacy, and a more precise ability to influence the body’s immune system. Increased trust in mRNA technology among global public health organizations, governments, and private investors has also led to increased spending on research and development.
Get free Sample Report of mRNA Technology Market: https://www.snsinsider.com/sample-request/5540
Major Players in the mRNA Technology Market Include:
In 2023, the Infectious Diseases segment dominated the mRNA technology market, accounting for over 70% of the market share due to the significant success of mRNA vaccines, particularly for COVID-19, which accelerated the global acceptance and application of mRNA technology. The Cancer Immunotherapy segment is the fastest growing within the mRNA technology market owing to the ongoing advancements in mRNA vaccines for cancer, where the technology is used to stimulate the immune system to target and destroy cancer cells.
By Delivery Method
In 2023, Lipid Nanoparticles held the largest share of the mRNA delivery method market, accounting for 80% of the mRNA technology market as they provide a reliable mechanism for protecting mRNA from degradation, facilitating its transport into cells, and enhancing overall vaccine efficacy. The Polymeric Carriers segment is the fastest growing in the mRNA delivery method category as they are emerging as promising tools for delivering mRNA vaccines and therapeutics more efficiently.
Regional Insights:
North America held the largest market share 43% in 2023, particularly due to the robust healthcare systems, increased government investments, and leading pharmaceutical companies in the region, such as Moderna and Pfizer.
Asia Pacific is experiencing rapid growth, driven by countries, such as China, Japan, and India. The region is witnessing a surge in mRNA vaccine development, with China increasing efforts in both research and manufacturing capabilities. Japan and India, with their established biotechnology sectors, are also becoming key players in mRNA technology, not only for vaccines but also for genetic and chronic disease therapies.
Buy the mRNA Technology Market Report Now: https://www.snsinsider.com/checkout/5540
Access Complete Report Details of mRNA Technology Market Analysis & Outlook: https://www.snsinsider.com/reports/mrna-technology-market-5540
[For more information or need any customization research mail us at [email protected]]
About Us:
SNS Insider is one of the leading market research and consulting agencies that dominates the market research industry globally. Our company’s aim is to give clients the knowledge they require in order to function in changing circumstances. In order to give you current, accurate market data, consumer insights, and opinions so that you can make decisions with confidence, we employ a variety of techniques, including surveys, video talks, and focus groups around the world.
